Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a med...
Publications
2 shownEffects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
Losartan conferred significant renal benefits in patients with type 2 diabetes and nephropathy, and it was generally well tolerated.
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 12,864
- Institution
- Baim Institute for Clinical Research
External Links
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.